ArticleClinical and translational radiation oncology2023

Comparison of four-year toxicities and local control of ultra-hypofractionated vs moderate-hypofractionated image guided prostate radiation with HDR brachytherapy boost: A phase I-II single institution trial.

M M Beaudry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.